Status:
COMPLETED
Validity and Reliability of the Turkish Version of HAnDE
Lead Sponsor:
Gazi University
Conditions:
Scleroderma
Hand Rheumatism
Eligibility:
All Genders
18-65 years
Brief Summary
The aim of the present study was to translate and cross-culturally adapt The Hand Scleroderma Experienced Experience (HAnDE) Scale into the Turkish language and investigate its reliability and validit...
Detailed Description
Objective: The aim of the present study was to translate and cross-culturally adapt The Hand Scleroderma Experienced Experience (HAnDE) Scale into the Turkish language and investigate its reliability ...
Eligibility Criteria
Inclusion
- 1\) being 18-65 years of age,
- 2\) being diagnosed of SSc according to do 2013 American College of Rheumatology (ACR) criteria and/or European League Against Rheumatism (EULAR) criteria,
- 3\) being literate in Turkish,
- 4\) being agreed to participate in the research.
Exclusion
- 1\) being in a psychological or cognitive disorders that would prevent to answer questions.
Key Trial Info
Start Date :
February 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2024
Estimated Enrollment :
77 Patients enrolled
Trial Details
Trial ID
NCT06536595
Start Date
February 1 2022
End Date
January 1 2024
Last Update
August 9 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Amasya University
Amasya, Turkey (Türkiye), 05000